1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Tissue Engineered Skin Substitutes Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Tissue Engineered Skin Substitutes Market, United Kingdom
3.1 Tissue Engineered Skin Substitutes Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Acellular Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.2 Cellular Skin Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Tissue Engineered Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Acellular Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.2 Cellular Skin Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Tissue Engineered Skin Substitutes Market, United Kingdom, Average Price ($) , 2018-2033
3.4 Tissue Engineered Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), 2023
3.5 Tissue Engineered Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United Kingdom, Tissue Engineered Skin Substitutes Market
4.1 Allergan Ltd
4.1.1 Company Overview
4.2 Integra LifeSciences Corp
4.2.1 Company Overview
4.3 Smith & Nephew Plc
4.3.1 Company Overview
5 Tissue Engineered Skin Substitutes Market Pipeline Products6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Smith & Nephew (Smith+Nephew) Raises USD350 Million in Public Offering of 5.15% Senior Notes Due 2027
6.1.2 Smith & Nephew (Smith+Nephew) Raises USD650 Million in Public Offering of 5.4% Senior Notes Due 2034
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Tissue Engineered Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Acellular Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Cellular Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 4: Tissue Engineered Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Table 5: Acellular Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Table 6: Cellular Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Table 7: Tissue Engineered Skin Substitutes Market, United Kingdom, Average Price ($), 2018-2033
Table 8: Tissue Engineered Skin Substitutes Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023
Table 9: Tissue Engineered Skin Substitutes Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023
Table 10: Tissue Engineered Skin Substitutes Market Pipeline Products
Table 11: Smith & Nephew (Smith+Nephew) Raises USD350 Million in Public Offering of 5.15% Senior Notes Due 2027
Table 12: Smith & Nephew (Smith+Nephew) Raises USD650 Million in Public Offering of 5.4% Senior Notes Due 2034
Table 13: Total Number of Primary Research Participants, Wound Care Management Market, by Country
List of Figures
Figure 1: Tissue Engineered Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Acellular Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cellular Skin Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 4: Tissue Engineered Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Figure 5: Acellular Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Figure 6: Cellular Skin Substitutes Market, United Kingdom, Volume (Units), 2018-2033
Figure 7: Tissue Engineered Skin Substitutes Market, United Kingdom, Company Share (%) 2023